We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
-1.27%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$283B
AUM Growth
+$27.4B
Cap. Flow
+$30.5B
Cap. Flow %
10.78%
Top 10 Hldgs %
36.77%
Holding
11,338
New
1,654
Increased
4,102
Reduced
3,903
Closed
1,507

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.35%
2 Technology 1.76%
3 Financials 1%
4 Communication Services 0.83%
5 Healthcare 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVFM
9626
PUT
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$24K ﹤0.01%
2,207
-746
-25% -$9.37K
PEI
9627
PUT
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$24K ﹤0.01%
827
-2,753
-77% -$84.3K
ADMA icon
9628
PUT
ADMA Biologics
ADMA
$2.22B
$23K ﹤0.01%
20,400
+2,100
+11% +$2.94K
MDRR
9629
Medalist Diversified Inc
MDRR
$19.8M
$23K ﹤0.01%
+1,146
New +$22.5K
ZFOXW
9630
DELISTED
ZeroFox Holdings, Inc. Warrants
ZFOXW
$23K ﹤0.01%
38,371
-282
-0.7% -$205
IZEA icon
9631
PUT
IZEA Worldwide
IZEA
$61.3M
$22K ﹤0.01%
2,825
-775
-22% -$6.79K
LSTA icon
9632
CALL
Lisata Therapeutics
LSTA
$9.55M
$22K ﹤0.01%
1,220
TMCWW
9633
TMC The Metals Company Warrants
TMCWW
$1.19M
$22K ﹤0.01%
+23,217
New +$31.3K
BLUA.WS
9634
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$22K ﹤0.01%
33,905
-50
-0.1% -$40
EFTRW
9635
DELISTED
eFFECTOR Therapeutics, Inc. Warrant
EFTRW
$22K ﹤0.01%
+14,062
New +$17.1K
GLAQW
9636
DELISTED
Globis Acquisition Corp. Warrant
GLAQW
$22K ﹤0.01%
35,450
BTCT icon
9637
BTC Digital
BTCT
$7.72M
$21K ﹤0.01%
+96
New +$31.7K
DNZ.WS
9638
DELISTED
D and Z Media Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
DNZ.WS
$21K ﹤0.01%
33,999
-222
-0.6% -$178
VSA
9639
VisionSys AI
VSA
$10.6M
$20K ﹤0.01%
+6
New +$27.7K
MARK
9640
CALL
DELISTED
Remark Holdings, Inc.
MARK
$20K ﹤0.01%
1,950
-2,530
-56% -$33.1K
HHLA.WS
9641
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$20K ﹤0.01%
42,600
ARBGW
9642
DELISTED
Aequi Acquisition Corp warrants
ARBGW
$20K ﹤0.01%
33,168
-240
-0.7% -$187
LJAQW
9643
DELISTED
LightJump Acquisition Corporation Warrant
LJAQW
$20K ﹤0.01%
37,759
+200
+0.5% +$133
LHC.WS
9644
DELISTED
Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
LHC.WS
$20K ﹤0.01%
30,870
+100
+0.3% +$78
TMPMW
9645
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
$20K ﹤0.01%
28,617
+100
+0.4% +$84
LIDRW icon
9646
AEye Inc Warrant
LIDRW
$69.2K
$19K ﹤0.01%
16,586
-1,532
-8% -$2.09K
TCRT icon
9647
Alaunos Therapeutics
TCRT
$4.86M
$19K ﹤0.01%
67
-584
-90% -$179K
TTOO
9648
CALL
DELISTED
T2 Biosystems, Inc
TTOO
$19K ﹤0.01%
+4
New +$20.1K
EUCRW
9649
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$19K ﹤0.01%
26,640
+40
+0.2% +$34
ASAP
9650
PUT
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$19K ﹤0.01%
1,050
-2,905
-73% -$77.9K

Similar funds

Jane Street's Q3 2021 Portfolio in Review

As of Q3 2021, Jane Street held 11,338 positions worth $283B, up 11% from $256B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jane Street deployed $30.5B of net new capital in Q3 2021, opening 1,654 new positions and adding to 4,102 existing holdings. Its largest new stake was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.3% of assets, down from 2.5% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MBS ETF, an estimated $1.01B trimmed.

  • Jane Street's largest Q3 2021 buy was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.
  • Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.64B increase.
  • Jane Street's biggest Q3 2021 reduction was iShares MBS ETF, cutting an estimated $1.01B.
  • Jane Street fully exited Vanguard Tax-Exempt Bond Index Fund in Q3 2021, selling an estimated $338M.
  • Jane Street's ten largest holdings make up 37% of its $283B portfolio in Q3 2021.
  • Jane Street opened 1,654 new positions and closed 1,507 in Q3 2021.
  • Jane Street's portfolio value rose 11% quarter-over-quarter to $283B.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.